During the past decade, Q&T Research Sherbrooke Inc conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 21 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Q&T Research Sherbrooke Inc" #1 sponsor was "Pfizer" with 7 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "AstraZeneca" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Allergy Therapeutics" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Q&T Research Sherbrooke Inc" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "MedQualis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Q&T Research Sherbrooke Inc" are "Alzheimer Disease" (5 trials), "Cardiovascular Disease" (4 trials), "Plaque Psoriasis" (3 trials), "Alzheimer's Disease" (2 trials) and "Chronic Cough" (2 trials). Many other conditions were trialed in "Q&T Research Sherbrooke Inc" in a lesser frequency.

Most popular intervention types in "Q&T Research Sherbrooke Inc" are "Drug" (32 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Lanabecestat" (3 trials), "Apremilast" (2 trials), "KLOX BioPhotonic System" (2 trials) and "PF-04950615 (RN316)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Q&T Research Sherbrooke Inc" are 38 trials for "All" genders.

Currently, there are NaN active trials in "Q&T Research Sherbrooke Inc". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Q&T Research Sherbrooke Inc, 1 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Q&T Research Sherbrooke Inc, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".